Log In
Print this Print this

NeoRecormon, epoetin beta (EPOCH, Epogin)

  Manage Alerts
Collapse Summary General Information
Company Chugai Pharmaceutical Co. Ltd.
DescriptionEpoetin beta
Molecular Target Erythropoietin (EPO) receptor
Mechanism of ActionErythropoietin (EPO) receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationAnemia
Indication DetailsEffect of early anemia treatment on cardiovascular parameters in diabetic patients with chronic kidney disease (CKD); Treat anemia; Treat anemia associated with chronic kidney disease (CKD); Treat cancer-related anemia; Treat chemotherapy-induced anemia (CIA)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today